Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.47 |
| ▸ | ATM | Q13315 | 1/20 | 0.47 |
| ▸ | PPARG | P37231 | 7/20 | 0.39 |
| ▸ | MEN1 | O00255 | 2/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | MAPT | P10636 | 2/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.37 |
| ▸ | NR1H2 | P55055 | 2/20 | 0.37 |
| ▸ | NR1H3 | Q13133 | 2/20 | 0.37 |
| ▸ | PPARA | Q07869 | 2/20 | 0.37 |
| ▸ | NTRK1 | P04629 | 1/20 | 0.35 |
| ▸ | IGF1R | P08069 | 1/20 | 0.35 |
| ▸ | FGFR1 | P11362 | 1/20 | 0.35 |
| ▸ | NTRK2 | Q16620 | 1/20 | 0.35 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.35 |
| ▸ | REN | P00797 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31497265 | 1.00 | KDM4E (0.47) | KDM4EL3MBTL1ATMPPARGMEN1 | |
| SCHEMBL26464409 | 0.91 | KDM4E (0.42) | KDM4EL3MBTL1ATMPPARGMEN1 | |
| SCHEMBL16890333 | 0.90 | KDM4E (0.57) | KDM4EL3MBTL1ATMPPARGMEN1 | |
| SCHEMBL14649186 | 0.86 | KDM4E (0.55) | KDM4EL3MBTL1ATMPPARGMEN1 | |
| SCHEMBL28477376 | 0.85 | KDM4E (0.61) | KDM4EL3MBTL1ATMPPARGNR1H2 | |
| SCHEMBL32661512 | 0.84 | KDM4E (0.47) | KDM4EL3MBTL1ATMPPARGMEN1 | |
| SCHEMBL26464393 | 0.84 | KDM4E (0.47) | KDM4EL3MBTL1ATMPPARGMEN1 | |
| SCHEMBL31497262 | 0.84 | KDM4E (0.41) | KDM4EL3MBTL1ATMPPARGMEN1 | |
| SCHEMBL22894369 | 0.84 | KDM4E (0.41) | KDM4EL3MBTL1ATMPPARGMEN1 | |
| SCHEMBL16890212 | 0.83 | KDM4E (0.53) | KDM4EL3MBTL1ATMPPARGMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230130170-A1 | LIGHT EMITTING DEVICE AND FUSED POLYCYCLIC COMPOUND FOR LIGHT EMITTING DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-04-27 | — | — | US | disclosed |
| US-20230130170-A1 | LIGHT EMITTING DEVICE AND FUSED POLYCYCLIC COMPOUND FOR LIGHT EMITTING DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-04-27 | — | — | US | disclosed |
| US-20210013423-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND FUSED POLYCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2021-01-14 | — | — | US | disclosed |
| CN-112194672-A | Organic electroluminescent device and condensed polycyclic compound | 三星显示有限公司 | 2021-01-08 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230130170-A1 | LIGHT EMITTING DEVICE AND FUSED POLYCYCLIC COMPOUND FOR LIGHT EMITTING DEVICE | LEF1, NFE2L2, CACNA2D1 | KDM4E 2826/4885L3MBTL1 257/4885ATM 4415/4885 |
| US-20210013423-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND FUSED POLYCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE | ODC1, PIEZO1, LEF1 | KDM4E 1832/4885L3MBTL1 551/4885ATM 3920/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.